Last Updated: 08/09/10
Workshop Presentations and Commentaries
Advanced Radiation Therapeutics — Radiation Injury Mitigation
NIH version (January 25, 2010)
Public version (January 25, 2010)
- What Are the Most Serious Adverse Events During and After Radiation Therapy? (MS PowerPoint)
- Toxicities in H&N Cancer: A Shifting Landscape (MS PowerPoint)
- Mechanisms of RT Toxicity (MS PowerPoint)
- A Patient Advocate's Perspective (MS PowerPoint)
- Patient-Reported Outcomes (PROs) (MS PowerPoint)
- Key Goals of Workshop (MS PowerPoint)
- Drugs for Combining with Radiotherapy: Drug Targets, the Pipeline and Evaluation (MS PowerPoint)
- Radiation Countermeasures: Interfacing with Clinical Oncology (MS PowerPoint)
- Mitigation of Chronic Radiation Injuries by ACE Inhibitors and AII Blockers (MS PowerPoint)
- Preclinical Guidelines: Development of Radioprotective/Mitigative Agents (MS PowerPoint)
- Preclinical Studies Showing Protection of Normal Tissues and Lack of Protection for Tumors (MS PowerPoint)
- Translational Research Program (TRP) (MS PowerPoint)
- Phase 0 Trials — Role in Radiation Mitigation Agent Development? (MS PowerPoint)
- Lessons from RTOG 9801 (MS PowerPoint)
- Designing Phase II or III Clinical Trials: Panel Discussion (MS PowerPoint)
- Designing Phase II or III Clinical Trials to Demonstrate RT Mitigation: The RTOG Example (MS PowerPoint)
- Advanced Radiation Therapeutics Radiation Injury Mitigation Workbook (PDF)
NCI-ASTRO Workshop Agenda
NCI Workshop in Advanced Technologies in Radiation Oncology
- Presentations (November 30-December 2, 2006)
- Reports (2009)
- Part I: Challenges and Resources B Vikram, CN Coleman, JA Deye
- Part II: State of the Science by Anatomic Site B Vikram, CN Coleman, JA Deye
- Commentary 1: Clinical Trials and Radiation Oncology Technologies WR Bosch, JA Purdy
- Commentary 2: Evaluating Advanced Technologies in Radiation Oncology: When and How Should Randomized Trials Be Done? G Sanguineti, TL Deweese
